Highlight Therapeutics
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Total raised
€38M
€37,600,000
Funding rounds
2
Investors
2
distinct backers
Active since
2021-02
latest 2025-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood28
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 16y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-16 | Other | €15M | Buenavista Equity Partners,Columbus Venture Partners | View deal → |
| 2021-02-04 | Other | €23M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel